Patent · US Active

Recombinant bacterium capable of eliciting a protective immune response against C. perfringens

US9040059B2 · kind B2 · utility

17Cited by
41References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 6, 2008
Grant dateMay 26, 2015
Priority date
Expiry dateApr 7, 2029

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention encompasses recombinant bacteria and immunogenic compositions comprising the bacteria. The immunogenic composition may be used to induce an immune response against C. perfringens.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.